Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Cash & Equivalents (2016 - 2025)

Bruker's Cash & Equivalents history spans 17 years, with the latest figure at $298.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 62.92% year-over-year to $298.8 million; the TTM value through Dec 2025 reached $298.8 million, up 62.92%, while the annual FY2025 figure was $298.8 million, 62.92% up from the prior year.
  • Cash & Equivalents reached $298.8 million in Q4 2025 per BRKRP's latest filing, up from $293.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q4 2021 to a low of $92.0 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $474.5 million, with a median of $530.6 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: tumbled 70.48% in 2024, then skyrocketed 97.91% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $1.1 billion in 2021, then tumbled by 39.57% to $645.5 million in 2022, then fell by 24.35% to $488.3 million in 2023, then plummeted by 62.44% to $183.4 million in 2024, then soared by 62.92% to $298.8 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Cash & Equivalents are $298.8 million (Q4 2025), $293.1 million (Q3 2025), and $92.0 million (Q2 2025).